Latest Drug delivery Stories
Global Intranasal Drug Delivery Market 2014-2018 market report profiles key vendors like Becton, Dickinson and Company, GlaxoSmithKline, Johnson & Johnson, Novartis, Actiza Pharmaceutical,
Broad spectrum of delivery forms is directed towards improving patient compliance SALT LAKE CITY and TORONTO, Aug.
MELBOURNE, Australia, Aug.
BETHESDA, Md., Aug.
Microneedle Patches and Subcutaneous Implants Offer Significant Revenue Potential, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug.
According to new report from BCC Research, the global market RNA interference (RNAi) drug delivery technologies is expected to grow to nearly $38.8 billion by 2018, with a five-year compound annual
Revenue for fiscal year 2014 anticipated to be at the high end of the $12 million to $15 million guidance range YORK, Pa., July 30, 2014 /PRNewswire/ -- Unilife Corporation ("Unilife"
Catalent Pharma Solutions, the global leader in drug development solutions and advanced delivery technologies for pharmaceutical, biologic, and consumer health products, today announced that Dr.
MELBOURNE, Australia, July 29, 2014 /PRNewswire/ -- -- Next phase of the TPM®/Oxymorphone clinical development program has commenced -- TPM®/Oxycodone Phase 2a trial to
- Growing in low tufty patches.